Clinical Trial

Evaluation of the Diagnostic Sensitivity and Specificity of the Determine™ Syphilis Advanced Test.

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 4, 2024 (before its estimated December 2024 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, multi-centre study which will evaluate the diagnostic sensitivity and specificity of the Determine™ Syphilis Advanced test. The test is intended for professional use and the performance evaluation will be performed by professional healthcare and laboratory staff. The study will also have a retrospective study arm. The Determine™ Syphilis Advanced validation will be conducted in accordance with the World Health Organization\'s TSS-6 guidance on Syphilis rapid diagnostic tests, ISO 20916 (In vitro diagnostic medical devices - Clinical performance studies using specimens from human subjects - Good study practice), the study protocol, Good Clinical Practice and the respective local medical device laws.
Trial Details
NCT Number NCT06584214
Lead Sponsor Abbott Rapid Dx
Conditions Syphilis Infection
Enrollment 400 participants
Start Date 2024-09
Primary Completion 2024-12 (estimated)
Study Completion 2024-12 (estimated)
Updated on ClinicalTrials.gov 2024-09-04